nefopam has been researched along with xav939 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alman, BA; Barrientos, T; Cutcliffe, H; Furman, B; Herfarth, J; Kwak, YH; Nwankwo, E; Puviindran, V; Zhang, H | 1 |
1 other study(ies) available for nefopam and xav939
| Article | Year |
|---|---|
Pharmacologic targeting of β-catenin improves fracture healing in old mice.
Topics: Analgesics, Non-Narcotic; Animals; beta Catenin; Fracture Healing; Heterocyclic Compounds, 3-Ring; Male; Mice, Inbred C57BL; Nefopam; Osteoblasts; Osteogenesis; Stem Cells; Tankyrases; Tibia; Tibial Fractures; Time Factors | 2019 |